Follow-up study | Weight difference (z scores) | % Underweight (< –2 z scores) | Height difference (z scores) | % Stunted (< –2 z scores) | Weight-for-height/length or BMI for age | % Wasted or low BMI (< –2 z scores) | Body composition and skin fold thickness | Body circumferences | Blood pressure | Other | |
---|---|---|---|---|---|---|---|---|---|---|---|
Bangladesh MINIMat | Khan et al. [42] Anthroa | Calculated difference: 0 (–0.114 to 0.114) | Calculated difference: –0.01 (–0.13 to 0.11) | 4.8 % (0.8–8.9) more stunting across all measurements | Calculated difference: Wt-for-ht z score, 0.01 (–0.09 to 0.11) | ||||||
Khan et al. [45] Body compa | Lean mass, 0.000 kg (–0.123 to 0.125 kg); fat mass, 0.001 kg (–0.058 to 0.061 kg); no difference in biceps, triceps, subscap or suprailiac skinfold thicknesses | Calculated difference: head, 0.02 cm (–0.20 to 0.24) MUAC, 0.11 cm (–0.04 to 0.26 cm) | |||||||||
Hawkesworth et al. [46] | Compared to 30 mg iron control adjusted for iron intervention dummy and food intervention variables: Systolic, 0.05 (–0.71 to 0.81); Diastolic, 0.55 (–0.10 to 1.20) | No difference in kidney volumes compared to 30 mg iron | |||||||||
Burkina Faso | Roberfroid et al. [35] | 0.13 (–0.01 to 0.27)b | Hazard ratio in 1st year of life 0.84 (0.70, 1.02) c | –0.02 (–0.18 to 0.14)b Length for age was significantly higher in the first year, but this disappeared by 30 months | Hazard ratio in 1st year of life, 0.73 (0.60–0.87)c | 0.20 (0.06–0.34)b Wt-for-ht was lower initially but higher in MMN from ≥ 10 months | Hazard ratio in 1st year of life, 1.10 (0.90–1.35)c | MUAC for age z, 0.18 (–2.93 to 3.29)b | |||
China | Wang et al. [41] | Pooled (1–30 months) adjusted difference: 0.03 (–0.05 to 0.10)d | Pooled (1-30 months) adjusted. OR 0.95 (0.71, 1.29) d | Pooled (1–30 months) adjusted difference, 0.02 (–0.07 to 0.10)d | Pooled (1–30 months) adjusted; OR, 0.82 (0.63–1.07)d | Pooled wt-for-length (1–30 months) adjusted difference, 0.03 (–0.05 to 0.11)d | Pooled wt-for-length (1–30 months) adjusted; OR, 0.89 (0.58–1.36)d | ||||
Mexico | Ramakrishnan et al. [38] | Calculated difference: –0.1 (–0.34 to 0.14) | Calculated difference: 0.2 (–0.08 to 0.48) | Calculated difference: Wt-for-ht –0.2 (–0.42 to 0.02) | Calculated difference: head, 0.2 cm (–0.42 to 0.82) | ||||||
Nepal Janakpur | Vaidya et al. [43] | 0.14 (0.00–0.27) | 37.8 % in control, 36.6 % in MMN | 0.08 (–0.06 to 0.22) | 60 % in control, 56.7 % in MMN | Wt-for-ht 0.12 (–0.02 to 0.26) | 5.5 % in control, 6.3 % in MMN | Triceps, 0.20 mm (0.00–0.40 mm) | Head, 0.24 cm (0.06–0.43 cm); MUAC, 0.24 cm (0.11–0.37 cm) | Systolic, –2.5 mmHg (0.47–4.55 mmHg); Diastolic, –1.5 mmHg (–3.1 to 0.4 mmHg) | |
Devakumar et al. [39] | 0.05 (–0.09 to 0.19) | Not recorded by trial group | 0.02 (–0.10 to 0.15) | Not recorded by trial group | BMI for age 0.04 (–0.09 to 0.18) | Not recorded by trial group | Lean mass, –0.05 kg (–0.43 to 0.34 kg); fat mass, –0.07 kg (–0.32 to 0.18 kg); no difference in biceps, triceps, subscapular and suprailiac skinfold thicknesses | Head, 0.18 cm (–0.02 to 0.38); MUAC, 0.04 (–0.15 to 0.23 cm) | Systolic, 0.02 mmHg (–1.02 to 1.05 mmHg); Diastolic, 0.13 mmHg (–0.93 to 1.19 mmHg) | No difference in kidney dimensions; exclusion of children with chronic or major illness made no difference | |
Nepal Sarlahi | Stewart et al. [44] | Calculated difference: –0.04 (95 % CI, –0.15 to 0.07)e | Calculated difference: 0.3 % (95 % CI, –5.4 to 6.0)e | Calculated difference: –0.02 (–0.13 to 0.09)e | Calculated difference: 3.7 % (–2.0–9.4)e | BMI for age calculated difference: –0.04 (–0.14 to 0.06)e | Triceps: FeFol + vit A, 5.84 mm; MMN, 5.9 mm; Subscap: MMN, 4.81 mm; FeFol + vit A 4.75 mm | MUAC: FeFol + vit A, 15.4 cm; MMN, 15.4 cm | |||
Stewart et al. [47] | Waist: FeFol + vita A, 51.27 cm; MMN, 51.22 cm | Systolic: FeFol + vit A, 95.2 mmHg; MMN, 95.5 mmHg; calculated difference, 0.29 mmHg (95 % CI, –0.65 to 1.23)d Diastolic: FeFol + vit A, 63.9 mmHg; MMN, 64.4 mmHg; calculated difference, 0.56 mmHg (95 % CI, –0.38 to 1.50)d | Non-fasting glucose: FeFol + vit A, 3.91 mmol/L; MMN, 3.86 mmol/L; LDL: FeFol + vit A, 1.89 mmol/L; MMN, 1.84 mmol/L; HDL: FeFol + vit A, 0.72 mmol/L; MMN, 0.70 mmol/L; at risk for metabolic syndrome: FeFol + vit A, 12.2 %; MMN, 11.9 % |